[go: up one dir, main page]

WO2019088958A3 - The use of jerusalem thorn fruits as herbal tea for diabetes treatment - Google Patents

The use of jerusalem thorn fruits as herbal tea for diabetes treatment Download PDF

Info

Publication number
WO2019088958A3
WO2019088958A3 PCT/TR2018/050591 TR2018050591W WO2019088958A3 WO 2019088958 A3 WO2019088958 A3 WO 2019088958A3 TR 2018050591 W TR2018050591 W TR 2018050591W WO 2019088958 A3 WO2019088958 A3 WO 2019088958A3
Authority
WO
WIPO (PCT)
Prior art keywords
jerusalem
herbal tea
diabetes treatment
thorn
fruits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2018/050591
Other languages
French (fr)
Other versions
WO2019088958A2 (en
Inventor
Kasim TAKIM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2019088958A2 publication Critical patent/WO2019088958A2/en
Publication of WO2019088958A3 publication Critical patent/WO2019088958A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates in particular to the use of antidiabetic active agent found in the fruits of the Jerusalem thorn (Paliurus spina-christi Mill.) plant which has been discovered to be able to compete with oral antidiabetic drugs in the treatment of diabetes patients.
PCT/TR2018/050591 2017-10-12 2018-10-12 The use of jerusalem thorn fruits as herbal tea for diabetes treatment Ceased WO2019088958A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201715541 2017-10-12
TR2017/15541 2017-10-12

Publications (2)

Publication Number Publication Date
WO2019088958A2 WO2019088958A2 (en) 2019-05-09
WO2019088958A3 true WO2019088958A3 (en) 2019-07-11

Family

ID=66331448

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050591 Ceased WO2019088958A2 (en) 2017-10-12 2018-10-12 The use of jerusalem thorn fruits as herbal tea for diabetes treatment

Country Status (1)

Country Link
WO (1) WO2019088958A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115957143A (en) * 2022-08-24 2023-04-14 广州辛选供应链有限公司 Composition for inhibiting AGEs, anti-aging, anti-yellowing and brightening skin and its preparation method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895510A (en) * 2006-06-18 2007-01-17 芮育健 Diabetes treatment by prepared rehmannia root, asiatic cornelian cherry fruit and Indian bread Yang-warm and kidney-nourishing

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895510A (en) * 2006-06-18 2007-01-17 芮育健 Diabetes treatment by prepared rehmannia root, asiatic cornelian cherry fruit and Indian bread Yang-warm and kidney-nourishing

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANTULUK Z.C. ET AL.: "Halk arasinda diyabete kargi kullanilan bitkiler (Tiirkiye) 2", HACETTEPE UNIVERSITESI ECZACILIK FAKIILTESI DERGISI, vol. 32, no. 2, 2012, pages 179 - 208, Retrieved from the Internet <URL:https://docplayer.biz.tr/349918-Halk-arasinda-diyabete-karsi-kullanilan-bitkiler-turkiye-ii.html> *
KALUVALA, R ET AL.: "Effect of Naringenin on streptozotocin induced diabetes in rats", INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH., vol. 4, January 2012 (2012-01-01), pages 40 - 43 *
MAHMOUD, MOSADDEGH ET AL.: "Study on the Effect of Paliurus spina-christi on Cholesterol, Triglyceride and HDL Levels in Diabetic Male Rats Fed a High Cholesterol Diet", IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, vol. 3, January 2004 (2004-01-01), XP055618916 *

Also Published As

Publication number Publication date
WO2019088958A2 (en) 2019-05-09

Similar Documents

Publication Publication Date Title
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
WO2015165413A8 (en) New stable antibody-drug conjugate, preparation method therefor, and use thereof
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
WO2015077503A8 (en) Autotaxin inhibitor compounds
WO2014141210A3 (en) Multifunctional immature dental pulp stem cells and therapeutic applications
PH12018500315A1 (en) Fumagillol heterocyclic compounds and methods of making and using same
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2017006437A (en) Spiro-isoquinoline-1,4&#39;-piperidine compounds having multimodal activity against pain.
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
EP4523542A3 (en) Human milk products useful in pre- and post-operative care
PH12020550050A1 (en) Novel acylated insulin analogues and uses thereof
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
WO2016029136A8 (en) 3-amidobenzamides and uses thereof for increasing cellular levels of a3g
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2019003725A (en) Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
GB201117490D0 (en) Anti-inflammatory compounds
WO2019088958A3 (en) The use of jerusalem thorn fruits as herbal tea for diabetes treatment
MX2018014136A (en) Tetrahydropyran and thiopyran derivatives having multimodal activity against pain.
MA39009A (en) Compositions pharmaceutiques comprenant un agent actif
WO2016032127A3 (en) Novel compounds having antioxidant and anti-inflammatory activities due to competition with lps for binding to tlr4, and medical use thereof
WO2016144706A3 (en) Autotaxin inhibitor compounds and uses thereof
WO2015126151A3 (en) Composition for wound healing comprising massa medicata fermentata extract
WO2016007042A3 (en) 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2,-diol epoxides, novel anti-parkinson&#39;s and antispasmodic drugs
MX2012014799A (en) Medicinal composition, preparation method and use thereof.

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18871831

Country of ref document: EP

Kind code of ref document: A2